OS Therapies Incorporated (NYSEAM: OSTX)
Health Care · Biotechnology · US
$1.59
-1.85% today · -25.7% 1Y
OS Therapies Incorporated (NYSEAM: OSTX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $72.15M and employs 5 people.
Over the last twelve months the share price has lost 25.7%, trading between 1.15 and 2.57.
Tweenvest scores OS Therapies Incorporated across four factors: quality 14/100. Its strongest factor is quality.
OSTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $72.15M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.05
- Dividend yield
- —
- Beta (5Y)
- -0.73
- 52-week high
- $2.57
- 52-week low
- $1.15
- Avg volume (3M)
- —
- Shares outstanding
- 44.54M
- Employees
- 5
- Next earnings
- —
About OS Therapies Incorporated
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
- Founded
- 2018
- Listed since
- Aug 1, 2024
- Exchange
- NYSE American LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.